dc.contributor.author | Alam S.E. |
dc.contributor.author | Nasser S. |
dc.contributor.author | Fernainy K.E. |
dc.contributor.author | Habib A.A. |
dc.contributor.author | Badr K.F. |
dc.contributor.editor | |
dc.date | Apr-2004 |
dc.date.accessioned | 2017-10-05T15:48:07Z |
dc.date.available | 2017-10-05T15:48:07Z |
dc.date.issued | 2004 |
dc.identifier | 10.1016/j.coph.2003.10.011 |
dc.identifier.isbn | |
dc.identifier.issn | 14714892 |
dc.identifier.uri | http://hdl.handle.net/10938/18671 |
dc.description.abstract | The excessive mortality of coronary heart disease is attributed primarily to rupture and thrombotic transformation of the atherosclerotic plaque. Inflammation plays a critical role in plaque destabilization and vulnerability. Inflammation is not confined to the culprit segment but is convincingly widespread in the coronary and remote vascular beds. Systemic inflammatory, thrombotic and hemodynamic factors are relevant to the pathological and clinical outcome. In addition to their fundamental role in thrombosis, there is ample evidence that platelets contribute significantly to promoting plaque inflammation. A new paradigm of unbalanced cytokine-mediated inflammation is emerging, providing diagnostic and therapeutic opportunity for intervention. Amplifying intrinsic anti-inflammatory mechanisms constitutes attractive avenues for future investigation. © Elsevier Ltd. All rights reserved. |
dc.format.extent | |
dc.format.extent | Pages: (166-170) |
dc.language | English |
dc.publisher | OXFORD |
dc.relation.ispartof | Publication Name: Current Opinion in Pharmacology; Publication Year: 2004; Volume: 4; no. 2; Pages: (166-170); |
dc.relation.ispartofseries | |
dc.relation.uri | |
dc.source | Scopus |
dc.subject.other | |
dc.title | Cytokine imbalance in acute coronary syndrome |
dc.type | Review |
dc.contributor.affiliation | Alam, S.E., American Univ. of Beirut Med. Center, Division of Cardiology, PO Box 113-6044, Beirut, Lebanon |
dc.contributor.affiliation | Nasser, S., American Univ. of Beirut Med. Center, Division of Cardiology, PO Box 113-6044, Beirut, Lebanon |
dc.contributor.affiliation | Fernainy, K.E., American Univ. of Beirut Med. Center, Division of Cardiology, PO Box 113-6044, Beirut, Lebanon |
dc.contributor.affiliation | Habib, A.A., American Univ. of Beirut Med. Center, Division of Cardiology, PO Box 113-6044, Beirut, Lebanon |
dc.contributor.affiliation | Badr, K.F., American Univ. of Beirut Med. Center, Division of Cardiology, PO Box 113-6044, Beirut, Lebanon |
dc.contributor.authorAddress | Alam, S.E.; American Univ. of Beirut Med. Center, Division of Cardiology, PO Box 113-6044, Beirut, Lebanon; email: salam@aub.edu.lb |
dc.contributor.authorCorporate | University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Office of the VP for Medical Affairs; |
dc.contributor.authorDepartment | Office of the VP for Medical Affairs |
dc.contributor.authorDivision | |
dc.contributor.authorEmail | salam@aub.edu.lb |
dc.contributor.faculty | Faculty of Medicine |
dc.contributor.authorInitials | Alam, SE |
dc.contributor.authorInitials | Nasser, SS |
dc.contributor.authorInitials | Fernainy, KE |
dc.contributor.authorInitials | Habib, AA |
dc.contributor.authorInitials | Badr, KF |
dc.contributor.authorOrcidID | |
dc.contributor.authorReprintAddress | Alam, SE (reprint author), Amer Univ Beirut, Ctr Med, Div Cardiol, POB 113-6044, Beirut, Lebanon. |
dc.contributor.authorResearcherID | |
dc.contributor.authorUniversity | American University of Beirut Medical Center |
dc.description.cited | Andre P, 2002, NAT MED, V8, P247, DOI 10.1038-nm0302-247; Andre P, 2002, CIRCULATION, V106, P896, DOI 10.1161-01.CIR.0000028962.04520.01; Asakura M, 2001, J AM COLL CARDIOL, V37, P1284, DOI 10.1016-S0735-1097(01)01135-4; AUKRUST P, 2001, HEART, V88, P605; Aukrust P, 2001, J AM COLL CARDIOL, V37, P485, DOI 10.1016-S0735-1097(00)01110-4; Blake GJ, 2002, EUR HEART J, V23, P923, DOI 10.1053-euhj.2001.3130; Blake GJ, 2001, EUR HEART J, V22, P349, DOI 10.1053-euhj.2000.2280; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161-01.CIR.0000020546.30940.92; Brasier AR, 2002, ARTERIOSCL THROM VAS, V22, P1257, DOI 10.1161-01.ATV.0000021412.56621.A2; Buffon A, 2002, NEW ENGL J MED, V347, P5, DOI 10.1056-NEJMoa012295; Burke AP, 2002, CIRCULATION, V105, P297, DOI 10.1161-hc0302.102610; Casscells W, 2003, CIRCULATION, V107, P2072, DOI 10.1161-01.CIR.0000069329.70061.68; Chan AW, 2003, CIRCULATION, V107, P1750, DOI 10.1161-01.CIR.0000060541.18923.E9; Chinetti G, 2001, NAT MED, V7, P53; Crisby M, 2001, CIRCULATION, V103, P926; Cybulsky MI, 2001, J CLIN INVEST, V107, P1255, DOI 10.1172-JCI11871; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016-S0140-6736(02)08089-3; DAMAS JK, 2003, CIRCULATION, V107, P260; Festa A, 2000, CIRCULATION, V102, P42; Fox KM, 2003, LANCET, V362, P782; Fry TJ, 2001, TRENDS IMMUNOL, V22, P564, DOI 10.1016-S1471-4906(01)02028-2; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084-jem.20011022; Haffner S, 2003, CIRCULATION, V108, P1541, DOI 10.1161-01.CIR.0000088845.17586.EC; Hajjar DP, 1997, J BIOL CHEM, V272, P22975, DOI 10.1074-jbc.272.37.22975; Collins R, 2002, LANCET, V360, P7; Heeschen C, 2003, CIRCULATION, V107, P2109, DOI 10.1161-01.CIR.0000065232.57371.25; Keaney JF, 2002, NEW ENGL J MED, V347, P55, DOI 10.1056-NEJM200207043470112; Kiechl S, 2003, ANN MED, V35, P164, DOI 10.1080-07853890310008215; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161-hc0902.104353; Libby P, 2001, CIRCULATION, V104, P365; Mallat Z, 2001, CIRC RES, V88, P998, DOI 10.1161-hh1001.090571; Mallat Z, 2001, CIRCULATION, V104, P1598, DOI 10.1161-hc3901.096721; Marx N, 2002, CIRC RES, V91, P373, DOI 10.1161-01.RES.0000033472.61704.CE; Moukarbel GV, 2001, CLIN CARDIOL, V24, P506; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038-nri702; PENG HB, 1995, J BIOL CHEM, V270, P14214; Plenge JK, 2002, CIRCULATION, V106, P1447, DOI 10.1161-01.CIR.0000029743.68247.31; Price DT, 1999, AM J MED, V107, P85, DOI 10.1016-S0002-9343(99)00153-9; Ridker PM, 2001, CIRCULATION, V103, P1813; Rioufol G, 2002, CIRCULATION, V106, P804, DOI 10.1161-01.CIR.0000025609.13806.31; Ross R, 1999, NEW ENGL J MED, V340, P115; Schoenhagen P, 2002, CIRCULATION, V106, P760, DOI 10.1161-01.CIR.0000025708.36290.05; Schonbeck U, 2001, CIRC RES, V89, P1092, DOI 10.1161-hh2401.101272; Smith DA, 2001, CIRCULATION, V104, P746, DOI 10.1161-hc3201.094973; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161-hh0901.090440; Weyand CM, 2001, MAYO CLIN PROC, V76, P1011; Wilson SH, 2002, ATHEROSCLEROSIS, V160, P147, DOI 10.1016-S0021-9150(01)00546-9; Yamashita H, 2003, AM J CARDIOL, V91, P133, DOI 10.1016-S0002-9149(02)03097-7; Yeh ETH, 2001, CIRCULATION, V104, P974; Zhou R H, 2001, J Atheroscler Thromb, V8, P30 |
dc.description.citedCount | 34 |
dc.description.citedTotWOSCount | 30 |
dc.description.citedWOSCount | 26 |
dc.format.extentCount | 5 |
dc.identifier.articleNo | |
dc.identifier.coden | COPUB |
dc.identifier.pubmedID | 15063361 |
dc.identifier.scopusID | 1842453952 |
dc.identifier.url | |
dc.publisher.address | THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND |
dc.relation.ispartofConference | |
dc.relation.ispartofConferenceCode | |
dc.relation.ispartofConferenceDate | |
dc.relation.ispartofConferenceHosting | |
dc.relation.ispartofConferenceLoc | |
dc.relation.ispartofConferenceSponsor | |
dc.relation.ispartofConferenceTitle | |
dc.relation.ispartofFundingAgency | |
dc.relation.ispartOfISOAbbr | Curr. Opin. Pharmacol. |
dc.relation.ispartOfIssue | 2 |
dc.relation.ispartOfPart | |
dc.relation.ispartofPubTitle | Current Opinion in Pharmacology |
dc.relation.ispartofPubTitleAbbr | Curr. Opin. Pharmacol. |
dc.relation.ispartOfSpecialIssue | |
dc.relation.ispartOfSuppl | |
dc.relation.ispartOfVolume | 4 |
dc.source.ID | WOS:000220780500010 |
dc.type.publication | Journal |
dc.subject.otherAuthKeyword | |
dc.subject.otherChemCAS | angiotensin, 1407-47-2 |
dc.subject.otherChemCAS | C reactive protein, 9007-41-4 |
dc.subject.otherChemCAS | interleukin 18, 189304-55-0 |
dc.subject.otherChemCAS | interleukin 8, 114308-91-7 |
dc.subject.otherChemCAS | Cytokines |
dc.subject.otherChemCAS | NF-kappa B |
dc.subject.otherIndex | angiotensin |
dc.subject.otherIndex | angiotensin receptor antagonist |
dc.subject.otherIndex | C reactive protein |
dc.subject.otherIndex | cytokine |
dc.subject.otherIndex | hydroxymethylglutaryl coenzyme A reductase inhibitor |
dc.subject.otherIndex | interleukin 10 |
dc.subject.otherIndex | interleukin 18 |
dc.subject.otherIndex | interleukin 6 |
dc.subject.otherIndex | interleukin 7 |
dc.subject.otherIndex | interleukin 8 |
dc.subject.otherIndex | monocyte chemotactic protein 1 |
dc.subject.otherIndex | Ras protein |
dc.subject.otherIndex | Rho factor |
dc.subject.otherIndex | tumor necrosis factor |
dc.subject.otherIndex | tumor necrosis factor alpha |
dc.subject.otherIndex | antiinflammatory activity |
dc.subject.otherIndex | atherosclerotic plaque |
dc.subject.otherIndex | clinical trial |
dc.subject.otherIndex | coronary blood vessel |
dc.subject.otherIndex | diagnostic procedure |
dc.subject.otherIndex | evidence based medicine |
dc.subject.otherIndex | heart muscle ischemia |
dc.subject.otherIndex | hemodynamics |
dc.subject.otherIndex | human |
dc.subject.otherIndex | inflammation |
dc.subject.otherIndex | ischemic heart disease |
dc.subject.otherIndex | mortality |
dc.subject.otherIndex | outcomes research |
dc.subject.otherIndex | priority journal |
dc.subject.otherIndex | review |
dc.subject.otherIndex | thrombocyte |
dc.subject.otherIndex | thrombosis |
dc.subject.otherIndex | Acute Disease |
dc.subject.otherIndex | Angina, Unstable |
dc.subject.otherIndex | Coronary Arteriosclerosis |
dc.subject.otherIndex | Coronary Thrombosis |
dc.subject.otherIndex | Cytokines |
dc.subject.otherIndex | Humans |
dc.subject.otherIndex | Myocardial Infarction |
dc.subject.otherIndex | NF-kappa B |
dc.subject.otherIndex | Signal Transduction |
dc.subject.otherIndex | Syndrome |
dc.subject.otherKeywordPlus | C-REACTIVE PROTEIN |
dc.subject.otherKeywordPlus | UNSTABLE ANGINA-PECTORIS |
dc.subject.otherKeywordPlus | CARDIOVASCULAR-DISEASE |
dc.subject.otherKeywordPlus | ATHEROSCLEROTIC PLAQUE |
dc.subject.otherKeywordPlus | VASCULAR INFLAMMATION |
dc.subject.otherKeywordPlus | PPAR-GAMMA |
dc.subject.otherKeywordPlus | KAPPA-B |
dc.subject.otherKeywordPlus | ATHEROGENESIS |
dc.subject.otherKeywordPlus | REDUCTION |
dc.subject.otherKeywordPlus | TRIAL |
dc.subject.otherWOS | Pharmacology and Pharmacy |
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |